Oramed Pharmaceuticals (ORMP) Enterprise Value Growth (3y) (2013 - 2026)
Oramed Pharmaceuticals (ORMP) Enterprise Value Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.77% |
| Dec 31, 2025 | 30.44% |
| Sep 30, 2025 | 21.37% |
| Jun 30, 2025 | 70.96% |
| Mar 31, 2025 | 16.20% |
| Nov 30, 2021 | -17.84% |
| Aug 31, 2021 | -149.13% |
| May 31, 2021 | -104.94% |
| Feb 28, 2021 | -93.03% |
| Nov 30, 2020 | -81.40% |
| Aug 31, 2020 | -61.64% |
| May 31, 2020 | -54.29% |
| Feb 29, 2020 | -14.00% |
| Nov 30, 2019 | 49.14% |
| Aug 31, 2019 | -1.30% |
| May 31, 2019 | -2.33% |
| Feb 28, 2019 | -63.42% |
| Nov 30, 2018 | -22.06% |
| Aug 31, 2018 | 27.95% |
| May 31, 2018 | 23.35% |